Learning Objective: After participating in this activity, learners should be better able to:
Evaluate the rationale for and current evidence supporting medication-assisted treatment of …

This paper reviews studies examining the pharmacological interactions and epidemiology of
the combined use of opioids and benzodiazepines (BZDs). A search of English language …

Aims To re‐examine various aspects of the benzodiazepines (BZDs), widely prescribed for
50 years, mainly to treat anxiety and insomnia. It is a descriptive review based on the Okey …

Drug interactions are a leading cause of morbidity and mortality. Methadone and
buprenorphine are frequently prescribed for the treatment of opioid addiction. Patients …

The British Association for Psychopharmacology guidelines for the treatment of substance
abuse, harmful use, addiction and comorbidity with psychiatric disorders primarily focus on …

ABSTRACT Background and Aims Benzodiazepines are commonly prescribed to patients
with opioid use disorder receiving buprenorphine treatment, yet may increase overdose risk …

Buprenorphine/naloxone (Suboxone®) comprises the partial μ-opioid receptor agonist
buprenorphine in combination with the opioid antagonist naloxone in a 4: 1 ratio. When …

Benzodiazepines (BZDs) are widely used by heroin users not in treatment, and by patients
in methadone and buprenorphine (BPN) treatment. This review examines the epidemiology …

Background Both methadone-and buprenorphine-treated opioid-dependent patients
frequently show cognitive deficits in attention, working memory, and verbal memory …

Abstract Background and Aims There is limited evidence on the relationship between
retention in opioid agonist treatment for opioid dependence and characteristics of treatment …